tiprankstipranks
Trending News
More News >

Annexon price target lowered to $14 from $20 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Annexon (ANNX) to $14 from $20 and keeps a Buy rating on the shares. The firm reduced the stock’s multiple and increased its discount rates to better align with current investor sentiment, elevated cost of capital, and reduced appetite for early-stage clinical risk. Annexon announced that it is on track to meet with the FDA for tanruprubart around Q2, the analyst tells investors in a research note.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue